As more research on psychedelic-assisted treatments surfaces, a coherent and consistent report on the psychotherapy aspect ...

Psychedelic-assisted psychotherapy is gaining attention as a promising approach to treat patients with mental disorders for ...

A clinical trial’s encouraging results won US Food and Drug Administration breakthrough therapy status for an LSD formulation to treat generalized anxiety disorder, Mind Medicine Inc. announced ...

The Department of Veterans Affairs will fund a study on psychedelic-assisted therapy for veterans for the first time in 80 ...

Psychedelic medicines specialist MindMed has said that its LSD-based treatment MM-120 has ... That will be crucial, to gauge whether the one-dose therapy is durable enough to make it a feasible ...

Despite the growing interest and media coverage, no major regulatory agency has yet approved psychedelics for specific medical use. Access to these treatments remains limited to clinical trials, ...

Psychedelic-assisted psychotherapy is gaining attention as a promising approach to treat patients with mental disorders for ...

Psychedelic-assisted psychotherapy is gaining attention as a promising approach to treat patients with mental disorders for whom conventional treatments have been insufficient.

suggests ketamine accompanied by therapy has much longer-lasting effects. Prof Morgan said there was mounting evidence that drugs, including psilocybin, LSD, ketamine and MDMA (Ecstasy), were safe ...

Although not a classic psychedelic (such as psilocybin and LSD), MDMA is a synthetic amphetamine ... professionals in conjunction with talking therapy to enhance patients' access, processing ...